Oxford BioMedica plc Share Price London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 | 89.54M 112M 8.95B | Sales 2024 * | 129M 162M 12.95B | Capitalization | 315M 395M 31.5B |
---|---|---|---|---|---|
Net income 2023 | -157M -197M -15.7B | Net income 2024 * | -36M -45.1M -3.6B | EV / Sales 2023 | 2.38 x |
Net cash position 2023 * | 49.23M 61.67M 4.92B | Net cash position 2024 * | 15.86M 19.87M 1.59B | EV / Sales 2024 * | 2.31 x |
P/E ratio 2023 |
-1.35
x | P/E ratio 2024 * |
-8.81
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 26/03/23 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 28/08/17 |
Chairman | 68 | 23/06/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 30/04/23 |
Chairman | 68 | 23/06/20 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 31/05/16 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+0.15% | 22.25B | |
-13.14% | 22.09B | |
-7.84% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |